Abstract:Atherosclerosis is a fatal disease for decades, which was thought to be the basis onset of many other cardiovascular diseases. Its pathogenesis is complex, mainly for the chronic vascular inflammation symptoms caused by abnormal lipid metabolism. Inflammation has been recognized as the pivotal role during every step of atherosclerosis. In view of the complication of its pathogenic process, the multi-target medication sometimes is more effective, less side effect and could reduce tolerance which should be another reasonable strategy for anti-atherosclerosis. Sphingomyelin synthase (SMS) is a potential therapeutic target for atherosclerosis treatment, while secretory phospholipase A2 (sPLA2) have been studied as a target of atherosclerosis treatment which plays an important role in the genesis and development of its progress of atherosclerosis. Based on the complex pathogenesis of atherosclerosis, we focused on two key enzymes in this process-SMS and sPLA2. We combined with the existing QSAR of the inhibitors of SMS and sPLA2 and rational multi-target drug design ideas, three series of dual inhibitors of sPLA2 and SMS were designed by linking or fusing SMS inhibitor fragment Ly18 (N-pyridine-3-amide moiety) with sPLA2 inhibitor fragment (indole-3-acetamide structure) by 3-6 carbon chain as novel dual-functional inhibitors series 1-3. Series 2 and 3 reserved benzyl in sPLA2 or SMS pharmacophore respectively, while series 1 was de-benzyl in order to decrease the molecular weight. Eleven target molecules were synthesized and bio-assayed in vitro. The results showed compounds 3a-3d provided inhibitory activities against SMS2 and 2a-2d exhibited the sPLA2 inhibition activities. The compound 3c showed equivalent activities of both SMS and sPLA2 which would be a potential leading compound of dual inhibitor against atherosclerosis.

Design and Synthesis of the Diazirine-based Clickable Photo-affinity Probe Targeting Sphingomyelin Synthase 2

Discovery of the Selective Sphingomyelin Synthase 2 Inhibitors with the Novel Structure of Oxazolopyridine

Design, Synthesis and Biological Evaluation of N,N-3-phenyl-3-benzylaminopropanamide Derivatives As Novel Cholesteryl Ester Transfer Protein Inhibitor

Discovery, Synthesis and Biological Evaluation of 2-(4-(n-phenethylsulfamoyl)phenoxy)acetamides (sapas) As Novel Sphingomyelin Synthase 1 Inhibitors

Identification of Small Molecule Sphingomyelin Synthase Inhibitors.

Design, Synthesis, and Biological Evaluation of Novel Dual Inhibitors of Secretory Phospholipase A2 and Sphingomyelin Synthase

Discovery of 4-Benzyloxybenzo[d]isoxazole-3-amine Derivatives As Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors That Reduce Chronic Inflammation in Db/db Mice

Molecular Modeling of the Three-Dimensional Structure of Human Sphingomyelin Synthase

Novel Dual Inhibitors of Secretory Phospholipase A2 and Sphingomyelin Synthase: Design, Synthesis and Evaluation

Discovery, Synthesis and Anti-Atherosclerotic Activities of a Novel Selective Sphingomyelin Synthase 2 Inhibitor.

Design and Synthesis of Small Molecule Probes of MDA-9/Syntenin

Analysis of Fluorescent Ceramide and Sphingomyelin Analogs: A Novel Approach for in Vivo Monitoring of Sphingomyelin Synthase Activity

Syntheses of Differentially Fluorinated Triazole-Based 1-Deoxysphingosine Analogues en route to SphK Inhibitors

Development, Validation, and Application of A Novel Method for Mammalian Sphingomyelin Synthase Activity Measurement

Design, Synthesis and Biological Activity of 3-Oxoamino-benzenesulfonamides As Selective and Reversible LSD1 Inhibitors.

A Near‐Infrared Fluorogenic Probe for Rapid, Specific, and Ultrasensitive Detection of Sphingosine in Living Cells and In Vivo

Click reactions with functional sphingolipids

Cooperative Multipoint Recognition of Sialic Acid by Benzoboroxole-Based Receptors Bearing Cationic Hydrogen-Bond Donors.

Development of a Quantitative Biochemical and Cellular Sphingomyelin Synthase Assay Using Mass Spectrometry

Development of diazirine–alkyne tag for protein–ligand interaction analysis with photoaffinity labeling

A facile method for monitoring sphingomyelin synthase activity in HeLa cells using liquid chromatography/mass spectrometry